705 related articles for article (PubMed ID: 35385985)
61. COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma.
Noumi T; Watanabe H; Ninomiya K; Ohashi K; Ichihara E; Kubo T; Makimoto G; Kato Y; Fujii M; Tabata M; Maeda Y; Hotta K; Kiura K
Acta Med Okayama; 2022 Oct; 76(5):593-596. PubMed ID: 36352807
[TBL] [Abstract][Full Text] [Related]
62.
Peacock JG; Banks EA; McWhorter N
J Nucl Med Technol; 2022 Mar; 50(1):73-74. PubMed ID: 34872921
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.
İşgören S; Köroğlu G; Görür GD; Demir H
Turk J Med Sci; 2022 Dec; 52(6):1745-1753. PubMed ID: 36945983
[TBL] [Abstract][Full Text] [Related]
64. Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine.
Burger IA; Husmann L; Hany TF; Schmid DT; Schaefer NG
Clin Nucl Med; 2011 Oct; 36(10):848-53. PubMed ID: 21892032
[TBL] [Abstract][Full Text] [Related]
65. Multicentric development and evaluation of
Lucia F; Bourbonne V; Pleyers C; Dupré PF; Miranda O; Visvikis D; Pradier O; Abgral R; Mervoyer A; Classe JM; Rousseau C; Vos W; Hermesse J; Gennigens C; De Cuypere M; Kridelka F; Schick U; Hatt M; Hustinx R; Lovinfosse P
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2514-2528. PubMed ID: 36892667
[TBL] [Abstract][Full Text] [Related]
66. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N
Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890
[TBL] [Abstract][Full Text] [Related]
67. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
[TBL] [Abstract][Full Text] [Related]
68. Assessing
Sarikaya I; Sarikaya A
J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
[No Abstract] [Full Text] [Related]
69. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
Zhang X; Wu F; Han P
Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
[TBL] [Abstract][Full Text] [Related]
70. Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies.
Orevi M; Chicheportiche A; Ben Haim S
J Nucl Med; 2022 Mar; 63(3):453-460. PubMed ID: 34301777
[TBL] [Abstract][Full Text] [Related]
71. Prediction of mediastinal lymph node metastasis based on
Yin G; Song Y; Li X; Zhu L; Su Q; Dai D; Xu W
Eur Radiol; 2021 Jun; 31(6):3983-3992. PubMed ID: 33201286
[TBL] [Abstract][Full Text] [Related]
72. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
Weeks JK; O'Brien SR; Rosenspire KC; Dubroff JG; Pantel AR
Clin Nucl Med; 2021 Dec; 46(12):1011-1012. PubMed ID: 34735411
[TBL] [Abstract][Full Text] [Related]
73. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
[TBL] [Abstract][Full Text] [Related]
74. Radiomics model based on features of axillary lymphatic nodes to predict axillary lymphatic node metastasis in breast cancer.
Tang Y; Che X; Wang W; Su S; Nie Y; Yang C
Med Phys; 2022 Dec; 49(12):7555-7566. PubMed ID: 35869750
[TBL] [Abstract][Full Text] [Related]
75. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
Ueda S; Tsuda H; Asakawa H; Omata J; Fukatsu K; Kondo N; Kondo T; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
BMC Cancer; 2008 Jun; 8():165. PubMed ID: 18541009
[TBL] [Abstract][Full Text] [Related]
76. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination.
Brophy J; Henkle G; Rohren EM
Clin Nucl Med; 2022 Feb; 47(2):174-175. PubMed ID: 34269723
[TBL] [Abstract][Full Text] [Related]
77. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
[TBL] [Abstract][Full Text] [Related]
78. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
79. Dual-time point
Park S; Paeng JC; Kang CH; Cheon GJ; Kang KW; Chung JK; Lee DS
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1317-1328. PubMed ID: 29502309
[TBL] [Abstract][Full Text] [Related]
80. A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
Guney IB; Dalci K; Teke ZT; Kucuker KA
Ann Ital Chir; 2020; 91():458-464. PubMed ID: 32213685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]